Načítá se...
Recent Advances in the Design and Development of Novel Negative Allosteric Modulators of mGlu(5)
[Image: see text] Negative allosteric modulators (NAMs) of metabotropic glutamate receptor subtype 5 (mGlu(5)) have remained attractive to researchers as potential therapies for a number of central nervous system related diseases, including anxiety, pain, gastresophageal reflux disease (GERD), addic...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical Society
2011
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3172159/ https://ncbi.nlm.nih.gov/pubmed/21927649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn2000266 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|